Drug · DIN 02359804
MINT-RISPERIDON
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 5, 2011; first marketed January 5, 2011.
- Drug Identification Number (DIN)
- 02359804
- Company (DIN owner)
- Mint Pharmaceuticals IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Risperidone N05AX08
- Class
- Human
- Record last updated
- June 26, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISPERIDONE | 0.50 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 8, 2010: NOC 11911Abbreviated New Drug Submission (ANDS) · New manufacturer and product name
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “mint-risperidon”. A notice may cover another product or only some lots: read it to see what it covers.
- Mint-Risperidon tablet: Out of specification (Impurity)September 27, 2024 · Drugs · Product quality · Type II
- Mint-Risperidon (2016-08-23)August 23, 2016 · Drugs · Product safety · Type III
Other DINs named MINT-RISPERIDON
- DIN 02359790 · Marketed
- DIN 02359812 · Marketed
- DIN 02359820 · Marketed
- DIN 02359839 · Marketed
- DIN 02359847 · Marketed